{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:32:33Z","timestamp":1780504353361,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Palliat Care"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12904-018-0292-6","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T19:10:22Z","timestamp":1519672222000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Development of the Japanese version of an information aid to provide accurate information on prognosis to patients with advanced non\u2013small-cell lung cancer receiving chemotherapy: a pilot study"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3952-5774","authenticated-orcid":false,"given":"Kikuo","family":"Nakano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kitahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mineyo","family":"Mito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misato","family":"Seno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Sunada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,27]]},"reference":[{"issue":"1","key":"292_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/caac.21254","volume":"65","author":"RL Siegel","year":"2015","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin. 2015;65(1):5\u201329.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"292_CR2","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1378\/chest.128.4.2933","volume":"128","author":"AL Visbal","year":"2005","unstructured":"Visbal AL, Leighl NB, Feld R, Shepherd FA. Adjuvant chemotherapy for early-stage non-small cell lung cancer. Chest. 2005;128(4):2933\u201343.","journal-title":"Chest"},{"issue":"1","key":"292_CR3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1093\/annonc\/mds214","volume":"24","author":"A Inoue","year":"2013","unstructured":"Inoue A, Kobayashi K, Maemondo M, Sugawara S, Oizumi S, Isobe H, Gemma A, Harada M, Yoshizawa H, Kinoshita I, et al. Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin-paclitaxel for chemo-na\u00efve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002). Ann Oncol. 2013;24(1):54\u20139.","journal-title":"Ann Oncol"},{"issue":"3","key":"292_CR4","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/ijc.24746","volume":"126","author":"T Tanaka","year":"2010","unstructured":"Tanaka T, Matsuoka M, Sutani A, Gemma A, Maemondo M, Inoue A, Okinaga S, Nagashima M, Oizumi S, Uematsu K, et al. Frequency of and variables associated with the EGFR mutation and its subtypes. Int J Cancer. 2010;126(3):651\u20135.","journal-title":"Int J Cancer"},{"issue":"28","key":"292_CR5","doi-asserted-by":"publisher","first-page":"4617","DOI":"10.1200\/JCO.2008.17.7162","volume":"26","author":"NSCLC Meta-Analyses Collaborative Group","year":"2008","unstructured":"NSCLC Meta-Analyses Collaborative Group. Chemotherapy in addition to supportive care improves survival in advanced non\u2013small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials. J Clin Oncol. 2008;26(28):4617\u201325.","journal-title":"J Clin Oncol"},{"issue":"14","key":"292_CR6","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1056\/NEJMsa012528","volume":"346","author":"TR Fried","year":"2002","unstructured":"Fried TR, Bradley EH, Towle VR, Allore H. Understanding the treatment preferences of seriously ill patients. N Engl J Med. 2002;346(14):1061\u20136.","journal-title":"N Engl J Med"},{"issue":"21","key":"292_CR7","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1001\/jama.279.21.1709","volume":"279","author":"JC Weeks","year":"1998","unstructured":"Weeks JC, Cook EF, O'Day SJ, Peterson LM, Wenger N, Reding D, Harrell FE, Kussin P, Dawson NV, Connors AF Jr, et al. Relationship between cancer patients\u2019 predictions of prognosis and their treatment preferences. JAMA. 1998;279(21):1709\u201314.","journal-title":"JAMA"},{"issue":"6","key":"292_CR8","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1177\/0269216307080823","volume":"21","author":"K Hancock","year":"2007","unstructured":"Hancock K, Clayton JM, Parker SM, Wal d S, Butow PN, Carrick S, Currow D, Ghersi D, Glare P, Hagerty R, et al. Truth-telling in discussing prognosis in advanced life-limiting illnesses: a systematic review. Palliat Med. 2007;21(6):507\u201317.","journal-title":"Palliat Med"},{"issue":"3","key":"292_CR9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.critrevonc.2004.09.002","volume":"52","author":"A Surbone","year":"2004","unstructured":"Surbone A, Ritossa C, Spagnolo AG. Evolution of truth-telling attitudes and practices in Italy. Crit Rev Oncol Hematol. 2004;52(3):165\u201372.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"292_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.socscimed.2003.10.006","volume":"59","author":"BT Slingsby","year":"2004","unstructured":"Slingsby BT. Decision-making models in Japanese psychiatry: transitions from passive to active patterns. Soc Sci Med. 2004;59(1):83\u201391.","journal-title":"Soc Sci Med"},{"issue":"3","key":"292_CR11","doi-asserted-by":"publisher","first-page":"204","DOI":"10.7326\/0003-4819-156-3-201202070-00008","volume":"156","author":"JW Mack","year":"2012","unstructured":"Mack JW, Cronin A, Taback N, Huskamp HA, Keating NL, Malin JL, Earle CC, Weeks JC. End-of-life care discussions among patients with advanced cancer: a cohort study. Ann Intern Med. 2012;156(3):204\u201310.","journal-title":"Ann Intern Med"},{"issue":"4","key":"292_CR12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1191\/0269216302pm575oa","volume":"16","author":"LJ Fallowfield","year":"2002","unstructured":"Fallowfield LJ, Jenkins VA, Beveridge HA. Truth may hurt but deceit hurts more: communication in palliative care. Palliat Med. 2002;16(4):297\u2013303.","journal-title":"Palliat Med"},{"issue":"13","key":"292_CR13","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1200\/JCO.2009.26.8425","volume":"28","author":"S Daneault","year":"2010","unstructured":"Daneault S, Dion D, Sicotte C, Yelle L, Mongeau S, Lussier V, Coulombe M, Paill\u00e9 P. Hope and noncurative chemotherapies: which affects the other? J Clin Oncol. 2010;28(13):2310\u20133.","journal-title":"J Clin Oncol"},{"issue":"9","key":"292_CR14","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1200\/JCO.2004.04.095","volume":"22","author":"RG Hagerty","year":"2004","unstructured":"Hagerty RG, Butow PN, Ellis PA, Lobb EA, Pendlebury S, Leighl N, Goldstein D, Lo SK, Tattersall MH. Cancer patient preferences for communication of prognosis in the metastatic setting. J Clin Oncol. 2004;22(9):1721\u201330.","journal-title":"J Clin Oncol"},{"issue":"9","key":"292_CR15","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00520-005-0789-4","volume":"13","author":"JM Clayton","year":"2005","unstructured":"Clayton JM, Butow PN, Arnold RM, Tattersall MH. Discussing life expectancy with terminally ill cancer patients and their carers: a qualitative study. Support Care Cancer. 2005;13(9):733\u201342.","journal-title":"Support Care Cancer"},{"key":"292_CR16","unstructured":"American Society of Clinical Oncology. Decision Aid for STAGE IV Non-Small Cell Lung Cancer (NSCLC) First-Line chemotherapy. \n                    http:\/\/www.asco.org\/sites\/new-www.asco.org\/files\/content-files\/practice-and-guidelines\/documents\/2009-nsclc-all-decision-aids.pdf"},{"issue":"2","key":"292_CR17","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/annonc\/mdl377","volume":"18","author":"Y Ohe","year":"2007","unstructured":"Ohe Y, Ohashi Y, Kubota K, Tamura T, Nakagawa K, Negoro S, Nishiwaki Y, Saijo N, Ariyoshi Y, Fukuoka M. Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: four-arm cooperative study in Japan. Ann Oncol. 2007;18(2):317\u201323.","journal-title":"Ann Oncol"},{"issue":"3","key":"292_CR18","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.lungcan.2012.04.017","volume":"77","author":"BE Kiely","year":"2012","unstructured":"Kiely BE, Alam M, Blinman P, Tattersall MH, Stockler MR. Estimating typical, best-case and worst-case life expectancy scenarios for patients starting chemotherapy for advanced non-small-cell lung cancer: a systematic review of contemporary randomized trials. Lung Cancer. 2012;77(3):537\u201344.","journal-title":"Lung Cancer"},{"issue":"10","key":"292_CR19","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1111\/j.1365-2648.1992.tb01843.x","volume":"17","author":"K Herth","year":"1992","unstructured":"Herth K. Abbreviated instrument to measure hope: development and psychometric evaluation. J Adv Nurs. 1992;17(10):1251\u20139.","journal-title":"J Adv Nurs"},{"issue":"1","key":"292_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jpainsymman.2004.04.016","volume":"29","author":"N Akizuki","year":"2005","unstructured":"Akizuki N, Yamawaki S, Akechi T, Nakano T, Uchitomi Y. Development of an impact thermometer for use incombination with the distress thermometer as a brief screening tool for adjustment disorders and\/or major depression in cancer patients. J Pain Symptom Manag. 2005;29(1):91\u20139.","journal-title":"J Pain Symptom Manag"},{"issue":"1","key":"292_CR21","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/j.1365-2354.2008.00967.x","volume":"19","author":"M Miyashita","year":"2010","unstructured":"Miyashita M, Yasuda M, Baba R, Iwase S, Teramoto R, Nakagawa K, Kizawa Y, Shima Y. Inter-rater reliability of proxy simple symptom assessment scale between physician and nurse: a hospital-based palliative care team setting. Eur J Cancer Care. 2010;19(1):124\u201330.","journal-title":"Eur J Cancer Care"},{"issue":"17","key":"292_CR22","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1056\/NEJMoa1204410","volume":"367","author":"JC Weeks","year":"2012","unstructured":"Weeks JC, Catalano PJ, Cronin A, Finkelman MD, Mack JW, Keating NL, Schrag D. Patients\u2019 expectations about effects of chemotherapy for advanced cancer. N Engl J Med. 2012;367(17):1616\u201325.","journal-title":"N Engl J Med"},{"issue":"2","key":"292_CR23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.suponc.2010.12.005","volume":"9","author":"TJ Smith","year":"2011","unstructured":"Smith TJ, Dow LA, Virago EA, Khatcheressian J, Matsuyama R, Lyckholm LJ. A pilot trial of decision aids to give truthful prognostic and treatment information to chemotherapy patients with advanced cancer. J Support Oncol. 2011;9(2):79\u201386.","journal-title":"J Support Oncol"},{"issue":"11","key":"292_CR24","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1634\/theoncologist.2013-0175","volume":"18","author":"KM Sjoquist","year":"2013","unstructured":"Sjoquist KM, Friedlander ML, O'Connell RL, Voysey M, King MT, Stockler MR, Oza AM, Gillies K, Martyn JK, Butow PN. Hope, quality of life, and benefit from treatment in women having chemotherapy for platinum-resistant\/refractory recurrent ovarian cancer: the gynecologic cancer intergroup symptom benefit study. Oncologist. 2013;18(11):1221\u20138.","journal-title":"Oncologist"},{"issue":"1","key":"292_CR25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/pon.921","volume":"15","author":"MM Barnett","year":"2006","unstructured":"Barnett MM. Does it hurt to know the worst? -psychological morbidity, information preferences and understanding of prognosis in patients with advanced cancer. Psychooncology. 2006;15(1):44\u201355.","journal-title":"Psychooncology"},{"issue":"5","key":"292_CR26","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/PPO.0b013e3181f30e07","volume":"16","author":"TC Campbell","year":"2010","unstructured":"Campbell TC, Carey EC, Jackson VA, Saraiya B, Yang HB, Back AL, Arnold RM. Discussing prognosis: balancing hope and realism. Cancer J. 2010;16(5):461\u20136.","journal-title":"Cancer J"},{"issue":"6","key":"292_CR27","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3747\/co.v16i6.432","volume":"16","author":"G Rodin","year":"2009","unstructured":"Rodin G, Zimmermann C, Mayer C, Howell D, Katz M, Sussman J, Mackay JA, Brouwers M. Clinician-patient communication: evidence-based recommendations to guide practice in cancer. Curr Oncol. 2009;16(6):42\u20139.","journal-title":"Curr Oncol"},{"issue":"10","key":"292_CR28","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1001\/jama.1995.03530100060035","volume":"274","author":"LJ Blackhall","year":"1995","unstructured":"Blackhall LJ, Murphy ST, Frank G, Michel V, Azen S. Ethnicity and attitudes toward patient autonomy. JAMA. 1995;274(10):820\u20135.","journal-title":"JAMA"},{"key":"292_CR29","first-page":"d1933","volume":"342","author":"HM Buiting","year":"2011","unstructured":"Buiting HM, Rurup ML, Wijsbek H, van Zuylen L, den Hartogh G. Understanding provision of chemotherapy to patients with end stage cancer: qualitative interview study. BMJ. 2011;342:d1933.","journal-title":"BMJ"},{"issue":"2","key":"292_CR30","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1207\/S15327027HC1402_4","volume":"14","author":"SA Kaplowitz","year":"2002","unstructured":"Kaplowitz SA, Campo S, Chiu WT. Cancer patients\u2019 desires for communication of prognosis information. Health Commun. 2002;14(2):221\u201341.","journal-title":"Health Commun"},{"issue":"2","key":"292_CR31","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00520-012-1526-4","volume":"21","author":"BE Kiely","year":"2013","unstructured":"Kiely BE, McCaughan G, Christodoulou S, Beale PJ, Grimison P, Trotman J, Tattersall MH, Stockler MR. Using scenarios to explain life expectancy in advanced cancer: attitudes of people with a cancer experience. Support Care Cancer. 2013;21(2):369\u201376.","journal-title":"Support Care Cancer"},{"issue":"10","key":"292_CR32","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1007\/s00520-011-1369-4","volume":"20","author":"K Pardon","year":"2012","unstructured":"Pardon K, Deschepper R, Vander Stichele R, Bernheim JL, Mortier F, Bossuyt N, Schallier D, Germonpr\u00e9 P, Galdermans D, Van Kerckhoven W, et al. Changing preferences for information and participation in the last phase of life: a longitudinal study among newly diagnosed advanced lung cancer patients. Support Care Cancer. 2012;20(10):2473\u201382.","journal-title":"Support Care Cancer"},{"issue":"11","key":"292_CR33","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1038\/sj.bjc.6604395","volume":"98","author":"NB Leighl","year":"2008","unstructured":"Leighl NB, Shepherd FA, Zawisza D, Burkes RL, Feld R, Waldron J, Sun A, Payne D, Bezjak A, Tattersall MH. Enhancing treatment decision-making: pilot study of a treatment decision aid in stage IV non-small cell lung cancer. Br J Cancer. 2008;98(11):1769\u201373.","journal-title":"Br J Cancer"},{"issue":"17","key":"292_CR34","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1200\/JCO.2010.32.4459","volume":"29","author":"JS Temel","year":"2011","unstructured":"Temel JS, Greer JA, Admane S, Gallagher ER, Jackson VA, Lynch TJ, Lennes IT, Dahlin CM, Pirl WF. Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: results of a randomized study of early palliative care. J Clin Oncol. 2011;29(17):2319\u201326.","journal-title":"J Clin Oncol"},{"issue":"8","key":"292_CR35","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJMoa1000678","volume":"363","author":"JS Temel","year":"2010","unstructured":"Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733\u201342.","journal-title":"N Engl J Med"},{"issue":"4","key":"292_CR36","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1001\/jamainternmed.2013.1874","volume":"173","author":"J Yoong","year":"2013","unstructured":"Yoong J, Park ER, Greer JA, Jackson VA, Gallagher ER, Pirl WF, Back AL, Temel JS. Early palliative care in advanced lung cancer: a qualitative study. JAMA Intern Med. 2013;173(4):283\u201390.","journal-title":"JAMA Intern Med"},{"issue":"26","key":"292_CR37","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1200\/JCO.2012.45.5865","volume":"31","author":"LM van Vliet","year":"2013","unstructured":"van Vliet LM, van der Wall E, Plum NM, Bensing JM. Explicit prognostic information and reassurance about nonabandonment when entering palliative breast cancer care: findings from a scripted video-vignette study. J Clin Oncol. 2013;31(26):3242\u20139.","journal-title":"J Clin Oncol"},{"issue":"33","key":"292_CR38","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.1200\/JCO.2016.66.8459","volume":"34","author":"DR Sullivan","year":"2016","unstructured":"Sullivan DR, Forsberg CW, Ganzini L, Au DH, Gould MK, Provenzale D, Slatore CG. Longitudinal changes in depression symptoms and survival among patients with lung cancer: a national cohort assessment. J Clin Oncol. 2016;34(33):3984\u201391.","journal-title":"J Clin Oncol"},{"issue":"35","key":"292_CR39","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1200\/JCO.2017.74.3062","volume":"35","author":"L Horn","year":"2017","unstructured":"Horn L, Spigel DR, Vokes EE, Holgado E, Ready N, Steins M, Poddubskaya E, Borghaei H, Felip E, Paz-Ares L, et al. Nivolumab versus docetaxel in previously treated patients with advanced non-small-cell lung cancer: two-year outcomes from two randomized, open-label, phase III trials (CheckMate 017 and CheckMate 057). J Clin Oncol. 2017;35(35):3924\u201333.","journal-title":"J Clin Oncol"}],"container-title":["BMC Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-018-0292-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T06:58:36Z","timestamp":1551250716000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpalliatcare.biomedcentral.com\/articles\/10.1186\/s12904-018-0292-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,27]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["292"],"URL":"https:\/\/doi.org\/10.1186\/s12904-018-0292-6","relation":{},"ISSN":["1472-684X"],"issn-type":[{"value":"1472-684X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,27]]},"assertion":[{"value":"12 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by National Hospital Organization Kure Medical Center research ethics review board, Hiroshima, Japan. All participants provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"38"}}